A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dacarbazine
Nafamostat
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Nafamostat.
Dacarbazine
Betrixaban
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Betrixaban.
Dacarbazine
Darexaban
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Darexaban.
Dacarbazine
Letaxaban
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Letaxaban.
Dacarbazine
Antithrombin III human
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Antithrombin III human.
Dacarbazine
Protein C
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Protein C.
Dacarbazine
Antithrombin Alfa
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Antithrombin Alfa.
Dacarbazine
Zinc citrate
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Zinc citrate.
Dacarbazine
Desirudin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Desirudin.
Dacarbazine
Parnaparin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Parnaparin.
Dacarbazine
Bemiparin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Bemiparin.
Dacarbazine
Dextran
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Dextran.
Dacarbazine
Sodium citrate
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Sodium citrate.
Dacarbazine
Potassium citrate
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Potassium citrate.
Dacarbazine
Edoxaban
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Edoxaban.
Dacarbazine
Vorapaxar
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Vorapaxar.
Dacarbazine
Ditazole
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Ditazole.
Dacarbazine
Ticagrelor
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Ticagrelor.
Dacarbazine
Triflusal
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Triflusal.
Dacarbazine
Nadroparin
The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Nadroparin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3